CDC to accelerate testing of new antibiotics using HP’s bioprinters

Date: 2018-08-29   Author: Pankaj Singh  Category: #technology

CDC to accelerate testing of new antibiotics using HP’s bioprinters

The Centers for Disease Control and Prevention (CDC) of the United States is reportedly employing HP’s Biohacker technology in a pilot program to print and test antibiotics, in a bid to restrict the fast spreading of antimicrobial resistant strains. Citing reliable sources, the pilot testing will be initially focusing on widely resistant bacteria and will be conducted at CDC’s regional labs in the first quarter of HP’s fiscal in 2019.       

According to trusted sources, CDC would be using HP’s D300e Digital Dispenser Bioprinter technology, which apparently utilizes the same set-up as a usual inkjet printer, but instead dispenses a mixed combination of drugs in volumes ranging from picolitres to microliters, for conducting research trials.

Reportedly, the bioprinter machines would be available at the regional labs in New York, Tennessee, Minnesota and Wisconsin for printing samples of drugs to be developed, along with conducting antimicrobial susceptibility test methods on the new drugs.

As per medical experts, the reason these bugs spread so rapidly comes down to inappropriate use of antibiotics, eventually enabling the bacteria to develop a strong resistance to the drugs. However, CDC plans on giving hospital nationwide access to the new technology to efficiently counter this issue. 

TechCrunch claims Jean Patel, PhD, Science Team Lead for CDC’s Antibiotic Resistance Coordination and Strategy Unit to have stated that in order to save lives, it is vital to make bioprinter technology accessible to hospital labs across the country. CDC hopes that the pilot trials would offer promising results on its newer drugs that would last longer and provide highly rated lab results to healthcare providers faster.

For the record, 3D bioprinting technology has been experiencing rapid growth over the past few years. The trend is anticipated to continue, mainly owing to research and development activities. in addition, 3D printing technology is supposedly moving towards printing human organs and tissues, besides drug research and developments.



About Author


Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Orthodontic Supplies Market Analysis, Manufacturers, Regions, Application, Forecast to 2032

Author: Rahul Varpe

DEC Research has recently published a study titled ‘Global Orthodontic Supplies Market Research Report’. In this report, analysts have provided a detailed evaluation of the global market. The report is inclusive of a completely compreh...


Transcatheter Heart Valve Replacement Market Opportunity, Major Driving Factors and Business Growth Strategies by 2026

Author: Rahul Varpe

DEC Research has recently published a study titled ‘Global Transcatheter Heart Valve Replacement Market Research Report’. In this report, analysts have provided a detailed evaluation of the global market. The report is inclusive of a c...


Digital Diabetes Management Market Application, Trends, Growth, Opportunities and Worldwide Forecast to 2030

Author: Rahul Varpe

DEC Research has published its most recent report with the title ‘Global Digital Diabetes Management Market In-depth Research on Industry Size, Trends, Emerging Growth Factors to 2030’. The report basically contains an outline of the i...